SOUTHERN JOURNAL OF SCIENCES

Background: Antioxidant compounds are widely used in medicine to protect the organism from the impact of various stresses and strengthen the immune system. The primary source of natural antioxidants is considered plant-based products. That is precisely why scientists are interested in extracting active compounds out of plant materials and use them. However, diverse resources of medicinal plants of Georgia is poorly studied and used as a source of antioxidants. Aim: The research aimed to study the antioxidant composition and total antioxidant activity of some dried medicinal plants sold in the pharmacy network in Tbilisi, Georgia. Methods: Several types of medicinal plants (3 berry plants and 3 herbaceous plants) sold in the pharmacy chain were chosen as the research object. These are Crataegus sp., Sorbus sp., Viburnum sp., Helichrysum sp., Leonurus quinquelobatus Gilib, Origanum vulgare L. Results: As a result, it has been found that the content of ascorbic acid and carotene in the studied plants is not so high to fill the daily intake of a man with an infusion prepared from one tablespoon. As for proline and the number of total antioxidants, all the plants we have chosen are high in content, considerably increasing their medicinal value. Discussion: The low amount of ascorbic acid and carotine found in studied plant, this increases their medicinal value, and in combination with other antioxidants/plants, the healing effect of the raw materials has been used. Conclusions: The studied plants are characterized by high levels of proline and antioxidant activity, so their infusions can be safely used as a source of antioxidants both in folk medicine and for the preparation of biologically active preparations.

Background: Diabetes Type 2 is a complex disorder described by an imbalance between insulin resistance and secretion that induce liver glucose output. It has been shown that serum insulin levels are affected by a sperm plasma membrane and acrosome. Therefore, during insulin resistance spermatogenesis changes, diabetic patients detect testicular changes. Aims: This research aims to know the effect of diabetic type 2 on some aspects of fertility in men by studying the characteristics of the semen and some biochemical parameters in seminal plasma. Methods: This study was achieved at the Center for Endocrinology and Diabetes Specialists in Maysan province from February to November 2018 and included 45 men (30 diabetic and 15 healthy in the control group) aged 30 to 59 years. The patients were divided according to age into two groups, the first (30-39) and second (40-59) years, also divided by the duration of diabetes into two groups, the first (1-5) and second (6-10) year. Results: The pH of semen in the second age group (40-49 years) group and first duration (1-5 years) group were significantly decreased (P <0.05) in diabetes compared with the control group. Volume and viscosity did not have significant differences in patients compared to the control following the age and duration of diabetes. Liquefaction only in the first age (30-39 years) group significantly increased (P <0.05) compared to the control. The concentration of sperm, progressive motility, non-progressive and normal morphology decreased (P <0.05) significantly. While the sluggish, dead, and abnormal morphology significantly increased (P <0.05) in all diabetes groups compared with the control. The fructose and alkaline phosphatase values in the seminal plasma were not differing significantly in patients compared with the control. Zinc and glutathione values decreased significantly (P <0.05) compared with control in each age and duration of diabetes. Discussion: Insulin stimulates the Ledying cell function, defect insulin effect on spermatogenesis. Impaired sperm motility in a patient with D.M. might be attributed to many reasons, such as increased ROS level, altered mitochondria DNA, and decreased epididymal products. Conclusion: our measurement indicates that there is an effect of type 2 diabetes mellitus on semen parameters and seminal plasma biochemical parameters.

Background: β-thalassemia is a blood disorder in which the body does not make hemoglobin normally. Aim: To assess serum sclerostin in female patients with beta-thalassemia and compare with the healthy controls and to predict its complication associated with the bone pathophysiology, for designed improvement the lifestyle goodliness for these patients. Material and methods: Sixty-nine female beta-thalassemia (βT) patients (54 βT major and 15 βT Intermedia), aged 8-40 years who dependent on transfused blood, and 20 healthy controls were evaluated serum sclerostin, and was examined the relationship with hematological parameters RBC, Hb, PCV, WBC, PLT, BMI, splenic status, iron, and ferritin levels. The information of beta-thalassemia patients was collected and records by the questioner. Results: A significantly increased serum sclerostin level (mean 26.80±0.91) pg/ml was showed in βT patients compared with the healthy controls (10.03±0.68, p  smaller than  0.001) pg/ml. Furthermore, a significant decrease (p smaller than 0.05) of the sclerostin level was observed in β-thalassemia major compared to intermedia β-thalassemia patients. Serum sclerostin level revealed a significant increase in progress age; it is highest in the age group (30-40) year as compared with age group (8-18) and (19-29) year respectively. Sclerostin showed no associations with the RBC, Hb, PCV, and significantly positively correlated (p smaller than 0.05) with serum iron, ferritin levels, WBC, and PLT count. Significantly higher sclerostin levels in splenectomized and underweight groups were observed compared to unsplenectomized and normal-weight groups (p smaller than 0.05) of βT patients. Conclusions: Sclerostin plays an important role in beta-thalassemia patients and can serve as a biomarker associated with the bone pathophysiology and indicator to prevent the continuation of such serious diseases caused by iron overload in these patients.